The roundup is formatted with the title of the story, followed by the news source in parentheses and a brief summary. If you find a particularly interesting article, please send it to smartin@asbmb.org for inclusion in next week’s roundup. The U.S. Senate Health, Education, Labor and Pensions committee will not introduce companion legislation to the U.S. House’s 21st Century Cures.
Today, the American Society for Biochemistry and Molecular Biology submitted a response to the U.S. House Energy and Commerce Committee’s discussion draft for the 21st Century Cures initiative.
In this four-part series, we will take a look at important issues for the research community in 2015. Today’s topic is the National Science Foundation. We already looked at 21st Century Cures and federal research funding. Our last post about the National Institutes of Health will come later this week.
In January, we published a series of five articles on science policy topics to watch in 2014. Let’s take a look at what happened with these issues. Federal research funding. On Jan. 22, President Obama signed the fiscal 2014 omnibus appropriations bill into law.
There has been a lot of congressional huffing and puffing recently challenging the validity of peer review. Some members of Congress are taking controversial stands, claiming that certain types of peer-reviewed, scientific research are a waste of taxpayer dollars.
U.S. Rep. Darrell Issa, R-Calif., added an amendment to NIH funding legislation that would defund three specific NIH peer-reviewed grants related to HIV/AIDS research. Particularly worrisome is that the amendment passed the House. While Issa’s amendment most likely will be removed in final versions of the bill funding NIH in 2010 (Labor/HHS/education appropriations), it is startling that such an amendment would be approved on the House floor.